Chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and other respiratory diseases are creating a huge burden on the public healthcare system in various countries across the world. Smoking, infections, and genetic factors can cause serious respiratory complications. Patients suffering from respiratory disorders usually experience breathing issues and oxygen shortages. Arterial blood gas (ABG) test is carried out to measure the amount of oxygen and carbon dioxide dissolved in arterial blood. The test helps deliver care to patients suffering from acute and chronic respiratory disease. Thus, the growing prevalence of acute and chronic respiratory diseases propels the demand for arterial blood gas test kits.
South and Central America region for the estimating the market for the arterial blood gas kits consist of countries such as Brazil, Argentina, and rest of South and Central America. The region is expected to experience growth opportunities due to increasing prevalence of respiratory disease in the countries and rise development in the healthcare systems. The market is also expected to grow due to the rising awareness about the respiratory disorders in the countries of the region.
As per a study titled “Prevalence of people at risk of developing type 2 diabetes and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil,” published in 2020, Brazil is one of the top ten countries across the world with numerous cases of diabetes.
Strategic insights for the South & Central America Arterial Blood Gas Kits provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market. The geographic scope of the South & Central America Arterial Blood Gas Kits refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.South & Central America Arterial Blood Gas Kits Strategic Insights
South & Central America Arterial Blood Gas Kits Report Scope
Report Attribute
Details
Market size in 2022
US$ 36.34 Million
Market Size by 2030
US$ 59.01 Million
Global CAGR (2022 - 2030)
6.2%
Historical Data
2020-2021
Forecast period
2023-2030
Segments Covered
By Product
By Technology
By Method
By Test Type
By Pathogen
Regions and Countries Covered
South and Central America
Market leaders and key company profiles
South & Central America Arterial Blood Gas Kits Regional Insights
The South & Central America arterial blood gas kits market is segmented into product, type, application, usage, needle gauge, syringe volume, end user, and country.
Based on product, the South & Central America arterial blood gas kits market is segmented into luer lock syringe and luer slip syringe. The luer lock syringe segment held a larger South & Central America arterial blood gas kits market share in 2022.
Based on type, the South & Central America arterial blood gas kits market is segmented into vented and non-vented. The non-vented segment held segment held a larger South & Central America arterial blood gas kits market share in 2022.
Based on usage, the South & Central America arterial blood gas kits market is segmented into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held a larger South & Central America arterial blood gas kits market share in 2022.
Based on application, the South & Central America arterial blood gas kits market is segmented into In vitro diagnostics, electrolyte analysis, and pH blood gas. The In vitro diagnostics segment held the largest South & Central America arterial blood gas kits market share in 2022.
Based on needle guage, the South & Central America arterial blood gas kits market is segmented into 23 G to 25 G and less than 23 G. The 23 G to 25 G segment held a larger South & Central America arterial blood gas kits market share in 2022.
Based on syringe volume, the South & Central America arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3 ml segment held the largest South & Central America arterial blood gas kits market share in 2022.
Based on end user, the South & Central America arterial blood gas kits market is segmented into hospitals, clinics, and others. The hospitals segment held the largest South & Central America arterial blood gas kits market share in 2022.
Based on country, the South & Central America arterial blood gas kits market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America arterial blood gas kits market in 2022.
Becton Dickinson and Co, ICU Medical Inc, Siemens Healthineers AG, Radiometer Medical ApS, ITL health Group Ltd, Medline Industries LP, Cardinal Health Inc, Fisher Scientific International, Inc, and Teleflex Inc, are some of the leading companies operating in the South & Central America arterial blood gas kits market.
The South & Central America Arterial Blood Gas Kits Market is valued at US$ 36.34 Million in 2022, it is projected to reach US$ 59.01 Million by 2030.
As per our report South & Central America Arterial Blood Gas Kits Market, the market size is valued at US$ 36.34 Million in 2022, projecting it to reach US$ 59.01 Million by 2030. This translates to a CAGR of approximately 6.2% during the forecast period.
The South & Central America Arterial Blood Gas Kits Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Arterial Blood Gas Kits Market report:
The South & Central America Arterial Blood Gas Kits Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Arterial Blood Gas Kits Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Arterial Blood Gas Kits Market value chain can benefit from the information contained in a comprehensive market report.